Group One Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$34K | – | 8401 |
|
|
2022
Q3 | $34K | Hold |
5,000
| – | – | ﹤0.01% | 5722 |
|
|
2022
Q2 | $21K | Buy |
+5,000
| New | +$19.8K | ﹤0.01% | 6267 |
|
|
2021
Q3 | – | Sell |
-2,500
| Closed | -$11K | – | 9005 |
|
|
2021
Q2 | $11K | Buy |
2,500
+800
| +47% | +$3.39K | ﹤0.01% | 7494 |
|
|
2021
Q1 | $8K | Sell |
1,700
-300
| -15% | -$2.42K | ﹤0.01% | 7139 |
|
|
2020
Q4 | $25K | Hold |
2,000
| – | – | ﹤0.01% | 5406 |
|
|
2020
Q3 | $20K | Buy |
+2,000
| New | +$19.7K | ﹤0.01% | 5139 |
|
|
2020
Q1 | – | Sell |
-11,000
| Closed | -$101K | – | 5926 |
|
|
2019
Q4 | $101K | Sell |
11,000
-56,400
| -84% | -$400K | ﹤0.01% | 3631 |
|
|
2019
Q3 | $396K | Sell |
67,400
-9,800
| -13% | -$104K | ﹤0.01% | 2532 |
|
|
2019
Q2 | $926K | Buy |
+77,200
| New | +$830K | 0.01% | 1650 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$13K | – | 5535 |
|
|
2018
Q4 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 4189 |
|
|
2018
Q3 | $15K | Buy |
+1,000
| New | +$15.7K | ﹤0.01% | 4506 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$3K | – | 5452 |
|
|
2017
Q4 | $3K | Sell |
100
-100
| -50% | -$2.01K | ﹤0.01% | 4659 |
|
|
2017
Q3 | $3K | Sell |
200
-57,000
| -100% | -$827K | ﹤0.01% | 4606 |
|
|
2017
Q2 | $798K | Buy |
57,200
+56,900
| +18,967% | +$839K | 0.01% | 1633 |
|
|
2017
Q1 | $5K | Buy |
+300
| New | +$3.6K | ﹤0.01% | 4297 |
|
|
2016
Q4 | – | Sell |
-2,000
| Closed | -$20K | – | 4956 |
|
|
2016
Q3 | $20K | Sell |
2,000
-100
| -5% | -$1.09K | ﹤0.01% | 3784 |
|
|
2016
Q2 | $24K | Buy |
2,100
+2,000
| +2,000% | +$25.5K | ﹤0.01% | 3711 |
|
|
2016
Q1 | $1K | Sell |
100
-3,900
| -98% | -$56.1K | ﹤0.01% | 4465 |
|
|
2015
Q4 | $76K | Hold |
4,000
| – | – | ﹤0.01% | 3168 |
|
|
2015
Q3 | $75K | Buy |
+4,000
| New | +$68K | ﹤0.01% | 3255 |
|
Group One Trading's CNCE Position: Q1 2023 in Review
Group One Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,891 shares — an estimated $11K sold.
Group One Trading first reported a position in CNCE in Q3 2015 and held it in 23 quarters. The position peaked at $399K in Q2 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Group One Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 1,891 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11K.
- Group One Trading first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 23 quarters.
- Group One Trading's Concert Pharmaceuticals, Inc. position peaked at $399K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.